The data underlying the results presented in the study are available from <https://doi.org/10.7910/DVN/NPYQBL>.

Introduction {#sec006}
============

Neonatal insults (NNI), defined as injury during the first 28 days of life, are associated with neonatal mortality, morbidity, and adverse neurodevelopmental outcome \[[@pone.0231947.ref001]\]. Globally, 5.9 million child deaths occur annually during the perinatal and neonatal periods \[[@pone.0231947.ref002], [@pone.0231947.ref003]\], accounting for 43% of deaths in children younger than 5 years of age \[[@pone.0231947.ref004]\]. Out of the total child-deaths that occur during this period, almost three-quarters occur in sub-Saharan Africa (SSA) and South Asia \[[@pone.0231947.ref005]\]. As part of the Millennium Developmental Goals, there was a global commitment to reduce childhood mortality by two-thirds between 1990 to 2015 \[[@pone.0231947.ref006]\]. Although the target was not fully achieved, there was a significant reduction in annual childhood mortality from 12.7 million in 1990 to 5.7 million in 2015 \[[@pone.0231947.ref007]\]. This reduction has increased attention about the long-term outcomes that may affect the functioning and quality of life of those children who survived early childhood conditions, and especially NNI (5).

Globally, the most common NNI include sepsis, congenital meningitis, hypoxic-ischemic encephalopathy (HIE), preterm birth, neonatal jaundice (NNJ), cytomegalovirus infection (CMV), herpes, congenital rubella, and toxoplasmosis \[[@pone.0231947.ref008]\]. Children who survive NNI are likely to develop adverse long-term outcomes such as neurocognitive impairment, developmental delay, hearing and visual impairment, cerebral palsy, and behavioral and emotional problems \[[@pone.0231947.ref009]--[@pone.0231947.ref015]\]. For instance, children who survived CMV were reported to develop sensorineural hearing loss and neurodevelopmental impairment \[[@pone.0231947.ref009]\], while congenital rubella is associated with hearing impairment \[[@pone.0231947.ref016], [@pone.0231947.ref017]\]. Intrauterine growth restriction (IUGR) is associated with neurodevelopmental impairment in the early years \[[@pone.0231947.ref012]\]; HIE was associated with motor and developmental delay during infancy \[[@pone.0231947.ref010]\], and NNJ was associated with adverse neurodevelopmental outcomes \[[@pone.0231947.ref008], [@pone.0231947.ref018]--[@pone.0231947.ref022]\].

There are few systematic reviews on the long-term outcomes of NNI. A review by Mwaniki et al. \[[@pone.0231947.ref008]\] included 153 studies with 22161 survivors of intrauterine insults with a follow-up period of at least 6 months and found that 39% of children who survive intrauterine or neonatal insults develop at least one long-term sequelae. The authors found that the survivors are likely to develop neurocognitive problems (cognitive impairment, developmental delays, and learning difficulties), visual and hearing impairment, and cerebral palsy. Mwaniki and colleagues also reported that congenital rubella and HIE had the highest prevalence of long-term sequelae (37% and 81% respectively) while NNJ has the lowest risk for long-term sequelae (18%).

Mwaniki et al.'s study reviewed studies with both short-term and long-term outcomes (from 6-months-old infants and older children); however, less is known about the long-term outcomes in school-aged children or older age groups globally who survived NNI \[[@pone.0231947.ref008]\]. As children grow older, their brains may compensate for brain injury during the neonatal period--a phenomenon termed brain plasticity \[[@pone.0231947.ref023]\]. Therefore NNI-associated impairments reported during early childhood may resolve as children grow older; it is, therefore, essential to identify on the residual neurodevelopmental sequelae at school-age and older age, which may persist and interfere with education, employment, and social functioning. This systematic review focuses on the long-term neurocognitive and mental health outcomes of NNI survivors who are six years or older.

Methods {#sec007}
=======

Literature search {#sec008}
-----------------

We conducted a comprehensive search for empirical literature in the following databases: PubMed, PsycINFO, Web of Science, Embase, and CINHAL. Relevant grey literature was searched in: ERIC, Open Grey, The Health Care Management Information Consortium (HMIC) database, the National Technical Information Service, and PsycEXTRA. We also used reference tracking to search for additional relevant literature. The detailed search terms (formulated by DNM and AA) comprised the index, and free terms of the different neonatal insults and the outcome measures combined with Boolean operators ("OR" and "AND") were used each database ([S1 Appendix](#pone.0231947.s002){ref-type="supplementary-material"}). The literature search included studies conducted from 1947 to 10^th^ October 2019. This systematic review is registered in PROSPERO (<https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=82119>); registration number CRD42018082119.

Inclusion and exclusion criteria {#sec009}
--------------------------------

Four reviewers (DNM, CN, EC, and AMM) independently screened the articles by titles, abstract, and full text for eligibility. Criteria for eligible studies were: i) empirical studies conducted in humans; ii) the study participants had follow-up data coinciding with the age bracket at 6 years or older (we considered children from six years as this is the age where most children join elementary school, especially in low-and-middle-income countries); iii) explicit diagnostic criteria for the neonatal insult, and iv) precise definition of the outcome and impairment (based on either a comparison to a control or a standardized test). Studies were excluded if i) it was not clear if the children had the diagnosis of NNI during the neonatal period (i.e., the first 28 days of life); ii) participants had another comorbid neural tube defect conditions, e.g. spina bifida; and iii) if the studies did not make a comparison to either a control or standardized test to define impairment in the outcomes.

Data extraction and quality assessment {#sec010}
--------------------------------------

Information extracted from the studies included: the author's name and year of publication, the country where the study was conducted, the sample size, age of participants at follow-up, study design, the type of neonatal insult, the assessment tools used, the neurocognitive or mental health outcome assessed, and a general summary of the study findings (see [S1 Table](#pone.0231947.s004){ref-type="supplementary-material"}). Quality assessment of the studies in this review was guided by the Newcastle-Ottawa scale (NOS) for assessment of the quality of cohort studies \[[@pone.0231947.ref024]\]. This quality assessment tool assigns a maximum of four points for selection, two points for comparability, and three points for exposure or outcome. The ranking of the total scores is as follows: 0--3 for low-quality studies, 4--6 for moderate quality, and 7--9 for high-quality studies. Both data extraction and quality assessment of the studies were independently done by two reviewers (DNM and AMM). In cases where the reviewers disagreed on articles included, disagreements were resolved by reassessment of the studies, discussions, and a third reviewer where necessary.

Data analysis {#sec011}
-------------

Descriptive statistics such as frequencies and percentages were used to describe the outcomes in different impairment domains for each neonatal insult, the geographic distribution of studies, and the NNI reported. Medians and interquartile range (IQR) of the proportions of survivors of the different NNI with any impairment were calculated.

The outcome variable was categorized into 6 major domains of impairment: i) neurodevelopmental impairment (cognition, language, developmental delay, memory); ii) hearing impairment; iii) vision impairment; iv) neurological impairment (cerebral palsy, clinical, and motor impairment); v) epilepsy; and vi) mental/behavioral problems. The criteria for the outcomes assessed and instruments used are provided in [S1 Table](#pone.0231947.s004){ref-type="supplementary-material"}. The variation in effect sizes attributed to heterogeneity was explored using *I*2 statistic of the DerSimonian and Laird method \[[@pone.0231947.ref025]\]. The 95% confidence interval (95% CI) around the *I*2 was used to express the uncertainty associated with the *I*2. A random-effect model was then used---after Freeman-Turkey Double Arcsine transformation---to explore the estimates accounted for by each impairment domain. Impairment domains represented by less than 3 studies per condition were excluded from this analysis. Data were analyzed using STATA (version 15) \[[@pone.0231947.ref026]\].

To explore the confounding effects of follow-up periods (6--12 years, 13--18 years, and \>18 years), study design (prospective vs retrospective), and region (North America, Asia, Europe, and Oceania) on the risk of impairment, a meta-regression was conducted for preterm birth only as other conditions had less than ten studies. To identify extreme findings, a visual inspection of the funnel plot was done, and Begg's adjusted rank correlation explored.

Results {#sec012}
=======

Fifty-two eligible studies ([S1 Appendix](#pone.0231947.s002){ref-type="supplementary-material"}) were included in this systematic review following a screening process that involved 80,038 articles (see [Fig 1](#pone.0231947.g001){ref-type="fig"}). Of the 52 eligible studies, 44.2% had an unexposed comparison group, while 55.8% only included an exposed group. For studies that had control groups, we report only on the case group (i.e. children who were diagnosed with NNI). More than half of the eligible studies were conducted in Europe (59.6%), 26.9% were conducted in North America, 7.7% were conducted in Asia, 5.8% were conducted in Oceania countries, and none in Africa. Most of the studies (76.9%) had a prospective study design, while 23.1% used a retrospective study design. A table with a summary of the characteristics of the studies is provided in [S1 Table](#pone.0231947.s004){ref-type="supplementary-material"}. The quality assessment of the 52 eligible studies indicates that 30 studies (57.7%) were categorized as "medium" quality while 22 studies (42.3%) were categorized as "high" quality (see [S2 Table](#pone.0231947.s005){ref-type="supplementary-material"}).

![Flow chart showing the selection of studies on long-term outcomes of neonatal insults.](pone.0231947.g001){#pone.0231947.g001}

Overall, 94,978 survivors of NNI were included in the studies in this review. The median number of participants per study was 125 (*IQR* = 78.5--281.5). The median age at follow-up was 8 years (6.0 to 10.0) years. The proportion of impairment among study participants aggregated by the form of NNI is summarized in [Table 1](#pone.0231947.t001){ref-type="table"}. The most examined or studied NNI were HIE (15.4%), NNJ (15.4%), and preterm birth (42.3%). The overall prevalence of impairment in the survivors of NNI was 10.0% (95% CI 9.8--10.2). The highest prevalence of impairment was accounted for by congenital rubella (38.8%: 95% CI 18.8--60.9), CMV (23.6%: 95% CI 9.5--41.5), and HIE (23.3%: 95% CI 14.7--33.1) while NNJ has the lowest proportion (8.6%: 95% CI 2.7--17.3). The most affected domain was the neurodevelopmental domain (16.6%: 95% CI 13.6--19.8). The frequency of impairment was highest for neurodevelopmental impairment \[22.0% (*IQR* = 9.2--24.8)\] and least for school problems \[0.0% (*IQR* = 0.0--0.00)\] in any of the conditions ([Table 2](#pone.0231947.t002){ref-type="table"}).

10.1371/journal.pone.0231947.t001

###### Summary of Proportion of Impairment in Survivors of Neonatal Insults.

![](pone.0231947.t001){#pone.0231947.t001g}

  Neonatal insult                                                                                                         ParticipantsAssessed   Impaired n (%)   Type of Impairment n (%)                                                                                                          
  ----------------------------------------------------------------------------------------------------------------------- ---------------------- ---------------- -------------------------- ----------- ------------ ------------- ------------ ------------- ----------- ------------ ----------- -------------
  Bacterial Meningitis \[[@pone.0231947.ref027]\]                                                                         111                    41 (36.9%)       41(36.9%)                  \-          \-           \-            \-           \-            \-          \-           \-          \-
  Birth Asphyxia \[[@pone.0231947.ref028]\]                                                                               54                     13 (24.1%)       13 (24.1%)                 \-          \-           \-            \-           \-            \-          \-           \-          \-
  CMV \[[@pone.0231947.ref029]--[@pone.0231947.ref031]\]                                                                  254                    191 (75.2%)      57 (22.4%)                 \-          \-           71 (27.9%)    21 (8.3%)    38 (15.0%)    2 (0.8%)    \-           2 (0.8%)    \-
  Congenital Rubella \[[@pone.0231947.ref016], [@pone.0231947.ref017], [@pone.0231947.ref032]--[@pone.0231947.ref034]\]   365                    322 (88.2%)      79 (21.6%)                 15 (4.1%)   8 (2.2%)     108 (29.6%)   29 (7.9%)    \-            \-          83 (22.7%)   \-          \-
  Fetal Growth Restriction \[[@pone.0231947.ref035]--[@pone.0231947.ref038]\]                                             2060                   552 (26.8%)      194 (9.4%)                 \-          14 (0.7%)    \-            \-           \-            10 (0.5%)   54 (2.6%)    \-          280 (13.6%)
  HIE \[[@pone.0231947.ref039]--[@pone.0231947.ref046]\]                                                                  500                    292 (58.4%)      128 (25.6%)                \-          70 (14.0%)   4 (0.8%)      3 (0.6%)     26(5.2%)      23(4.6%)    12 (2.4%)    26 (5.5%)   \-
  Neonatal Jaundice \[[@pone.0231947.ref047]--[@pone.0231947.ref054]\]                                                    79,356                 6586 (8.3%)      6212 (7.8%)                \-          \-           374 (0.5%)    \-           \-            \-          \-           \-          \-
  Preterm birth \[[@pone.0231947.ref055]--[@pone.0231947.ref076]\]                                                        12,278                 1531(12.5%)      1068 (8.8%)                2(0.0)      5(0.04)      6 (0.1)       108 (0.9%)   133 (1.08%)   69 (0.6%)   117(1.0%)    5 (0.1%)    3 (0.1%)

CMV- congenital Cytomegalovirus infection

10.1371/journal.pone.0231947.t002

###### Medians and Interquartile Range (IQR) of the Proportions of Impairment in Survivors of Neonatal Insults.

![](pone.0231947.t002){#pone.0231947.t002g}

  Type of Impairment   Overall            Neonatal Insults                                                                                                                           
  -------------------- ------------------ ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------ -------------------
  Neurodevelopmental   22.0 (9.2--24.8)   36.9 (36.9--36.9)   24.1 (24.1--24.1)   27.5 (8.2--46.9)    32.7 (5.0--34.5)    26.1 (15.6--31,7)   34.1(19.8--48.1)    11.6 (0.9--19.4)   25.1 (14.1--42.0)
  Clinical             0.0 (0.0--0.0)     \-                  \-                  \-                  30.0 (30.0--30.0)   \-                  \-                  \-                 2.2 (2.2)
  Mental               0.0 (0.0--1.4)     \-                  \-                  \-                  8.8 (7.5--10.0)     11.4 (11.4--11.4)   86.1 (86.1--86.1)   \-                 5.6 (5.6--5.6)
  Hearing              0.3 (0.0--13.2)    \-                  \-                  36.9 (15.0--58.7)   72.1 (31.5--98.0)   \-                  3.6 (3.6--3.6)      0.5 (0.0--0.9)     6.7 (6.7--6.7)
  Vision               0.3 (0.0--4.4)     \-                  \-                  18.6 (18.6--18.6)   29.8 (7.5--52.0)    \-                  2.7 (2.7--2.7)      \-                 24.6 (23.3--35.8)
  Motor                2.7 (0.0--3.1)     \-                  \-                  33.6 (33.6--33.6)   \-                  \-                  25.7 (15.3--36.0)   \-                 10.0 (8.2--22.5)
  Cerebral palsy       0.8 (0.0--0.4)     \-                  \-                  1.8 (1-8-1.8)       \-                  1.9 (1.9--1.9)      27.5 (23.1--32.0)   \-                 5.5 (4.2--7.2)
  Behavior             0.5 (0.0--2.5)     \-                  \-                  \-                  41.0 (33.7--48.3)   10.1 (10.1--10.1)   11.6(7.3--16.0)     \-                 19.1 (18.1--21.0)
  Epilepsy             0.0 (0.0--0.4)     \-                  \-                  1.8 (1.8--1.8)      \-                  \-                  13.9 (13.5--14.3)   \-                 5.6 (5.6--5.6)
  School problems      0.0 (0.0--0.0)     \-                  \-                  \-                  \-                  14.2 (11.9--16.6)   \-                  \-                 \-

CMV- congenital Cytomegalovirus infection; HIE--Hypoxic Ischemic Encephalopathy; Entries are median (IQR).

In this meta-analysis, the highest prevalence of neurodevelopmental impairment was accounted for by HIE (31.6%: 95% CI 19.6--45.0) ([Fig 2](#pone.0231947.g002){ref-type="fig"}) and preterm birth (25.2%: 95% CI 15.1--36.8) ([Fig 3](#pone.0231947.g003){ref-type="fig"}). The prevalence of neurodevelopmental impairment in NNJ was 10.3% (95% CI 2.2--23.2) ([Fig 4](#pone.0231947.g004){ref-type="fig"}). Hearing impairment was most prevalent in congenital rubella (78.6: 95%CI 16.4--100.0) ([Fig 5](#pone.0231947.g005){ref-type="fig"}), while visual impairment was common in preterm birth (27.6%: 95% CI 20.6--35.2) ([Fig 3](#pone.0231947.g003){ref-type="fig"}). We conducted a subgroup analysis of 15 preterm birth studies with extremely low birth weight participants, and similar results were obtained. The least affected domains were mental health problems for fetal growth restriction (17.1%: 95% CI 12.6--22.2) ([Fig 6](#pone.0231947.g006){ref-type="fig"}) and neurological impairment in preterm birth (11.1%: 95% CI 6.1--17.2) ([Fig 5](#pone.0231947.g005){ref-type="fig"}). The meta-analysis was not possible for CMV due to the limited number of studies.

![Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of fetal growth restriction.\
*I*2- heterogeneity statistic; ES- effect size; %---percent; sub-groups with (*I*2 = . %, p = .) indicate that the number of studies were too few for the estimates to be calculated.](pone.0231947.g002){#pone.0231947.g002}

![Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Preterm Birth.\
*I*2- heterogeneity statistic; ES- effect size; %---percent; sub-groups with (*I*2 = . %, p = .) indicate that the number of studies were limited for the estimates to be calculated.](pone.0231947.g003){#pone.0231947.g003}

![Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Neonatal Jaundice.](pone.0231947.g004){#pone.0231947.g004}

![Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Congenital Rubella.\
*I*2- heterogeneity statistic; ES- effect size; %---percent; sub-groups with (*I*2 = . %, p = .) indicate that the number of studies were limited for the estimates to be calculated.](pone.0231947.g005){#pone.0231947.g005}

![Individual and pooled estimates and 95% confidence intervals for random-effects model examining the long-term outcomes of Hypoxic-ischemic encephalopathy.](pone.0231947.g006){#pone.0231947.g006}

We did not find any statistically significant results from the meta-regression of the pooled proportion of impairment in preterm birth when the predictive factors of age at follow-up, region, and study design were included in the model. The funnel plot indicated an asymmetric plot confirming publication bias. The studies also had high heterogeneity which explains the asymmetry observed in the funnel plots.

Discussion {#sec013}
==========

This systematic review identified 52 studies that evaluated the long-term outcomes of NNI in school-aged children and older groups. Despite the limited data in these age groups, our study found 10% overall prevalence of impairment in survivors of NNI at age 6 years and above. The neurodevelopmental domain was the most commonly affected. Congenital rubella and HIE accounted for the highest frequency of impairment, while NNJ accounted for the least impairment.

Our findings that the neurodevelopmental domain is the most affected are similar to the results by Mwaniki and colleagues \[[@pone.0231947.ref008]\], however, the frequency was higher in their study (59% compared to 16.6% in the present study), and their samples comprised younger age-groups. These differences potentially demonstrate that neurodevelopmental impairment diminishes with age in most survivors due to the plasticity of the brain \[[@pone.0231947.ref008]\]. Another plausible reason may be that children with severe neurodevelopmental impairment did not survive to older age, thereby leading to a diminished proportion observed in older ages. It is also likely that the burden of neurodevelopmental impairment in low and middle-income resource settings like SSA may not be well represented by existing research. Moreover, not all the studies in this current review have reported on all domains of impairment; it is possible that the burden in certain domains is underestimated. There is a need for more comprehensive longitudinal studies from SSA to better characterize the impact of NNI.

Similar to the results by Mwaniki and colleagues \[[@pone.0231947.ref008]\], congenital rubella and HIE were associated with the most frequent adverse long-term outcomes. A possible explanation regards to the pathogenesis of these conditions. Congenital rubella, affects the systemic organs of neonates \[[@pone.0231947.ref077]\] and causes cell and tissue damage, and is associated with ocular, heart, and hearing impairment. In individuals affected by HIE, the blood circulation or blood flow to the brain is impaired, leading to decreased oxygen and energy to the brain. This decrease in oxygen and energy can result in brain cell death and additional scar to the white matter or neuronal cell death in severe hypoxia \[[@pone.0231947.ref078]\], which may result in irreversible brain damage.

Although three-quarters of child deaths occur in SSA and South Asia, many of which are related to NNI, studies in Africa that examine the long-term outcome of NNI are scarce, and none was included in this review. The lack of research in these age groups could be attributed to the lack of appropriate assessment tools, inadequate access to health-care, or lack of research expertise in this area. This is unfortunate and has serious implications as school-aged children, or older age groups who survived NNI, but live with some degree of impairment may not receive the needed care and attention. Therefore, their potential outcomes are not fully optimized; hence, they may miss required support, such as getting specialized education and continue to be marginalized.

The major strengths of this study are the use of multiple databases and a focus on long-term outcomes that are often not well studied. Additionally, the study utilized a rigorous study design for systematic reviews and meta-analysis. Lastly, the study focuses on a global perspective and further sub-categorizes the domains of impairment, making it comprehensive.

However, this study has several limitations. First, the study inclusion criteria were strict and may have omitted some studies that could be included, e.g. studies that did not include a confirmed diagnosis in the first 28 days of life (e.g., vertical HIV infection). Second, the inclusion of all children with a diagnosis of NNJ or HIE in the study without considering the severity levels might have diluted our sample.

Third, in this review, a few studies reported multi-domain impairments in the patients. For instance, many participants with cerebral palsy will also have motor impairment and learning difficulties, which we found complex to conduct subgroup analysis. Fourth, the studies included were highly heterogeneous. However, we used the random effect model, which accounted for unexplained heterogeneity observed in the studies \[[@pone.0231947.ref079]\]. Lastly, the results of this study should be cautiously interpreted as we found publication bias indicated by the asymmetric forest plot, which may imply that studies with statistically significant results were more likely to be published than those with non-significant results. The publication bias could also reflect the high heterogeneity in the studies included in this systematic review and meta-analysis.

These results have several implications for research and prevention strategies. The review identifies that various forms of NNI have several adverse long-term outcomes, which necessitates further management and close monitoring of survivors of NNI. Despite the improvements in neonatal care and management of birth complications to prevent child mortality, there is still need for treatment and improved care for child survivors of NNI to protect the central nervous system and prevent adverse long-term outcomes. More resources should be allocated for longer follow-ups of survivors of NNI and preventive and rehabilitative services provided to them to optimize their outcomes. Long-term follow-up research is also needed to better understand the outcomes of NNI, especially in SSA where there is a high burden of NNI, and proper medical care is limited.

Conclusion {#sec014}
==========

NNI have long-term consequences that are experienced far beyond early childhood to older ages. The major impairments arising from NNI are recorded in the neurodevelopmental domains (cognition, language, developmental delay, and memory). However, this finding is based on studies from high-income countries such as Europe and America with the state of art of care for children. There are no robust studies on long-term outcomes of NNI in SSA despite the high burden of NNI in this region. Therefore, more investment of longer follow-ups of survivors of NNI is needed in SSA to optimize their outcomes fully.
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Did you consider any NNJ or HIE as a neonatal insult? If yes your sample size is diluted. It would help if you include high risk insults such as NNJ requiring intensive phototherapy or exchange transfusion and moderate to severe HIEs.

Similarly a subgroup analysis of preterm birth by weight (ELBW, VLBW) will help.

Discussion

Overall discussion is well written, however following points may need attention.

1\) Publication bias needs to be discussed

2\) High heterogeneity is important. Random effect model may be useful, however a subgroup analysis of studies with lower heterogeneity is important (example I2 \<60%)

3\) No mention of any missing data and approach to address this important issue.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Review Comments to the Author

Methods:

1\) Is there a reason to choose the follow-up limit of 6 years?

� We considered children from six years of age, as this is the age where most children join elementary school, especially in low-and-middle-income countries. We have amended this part as follows:

Criteria for eligible studies were: i) empirical studies conducted in humans; ii) the study participants had follow-up data coinciding with the age bracket at six years or older (we considered children from six years as this is the age where most children join elementary school, especially in low-and-middle-income countries) (page 5, line 63-66).

Data extraction and analysis

2\) Did you contact the authors for any missing data?

� We had 65 articles which could not be accessed online. Most of them were older than two decades (probably not archived online). Out of these, in 50 articles we were not able to find the contact details of the corresponding authors, in one article our email was not delivered (the author had probably left the institution and changed their email addresses). Nine authors did not respond to our emails even after three reminders. Five authors sent us full articles; however, these did not meet the inclusion criteria.

Additionally, there were 35 articles with a wide age range (e.g. 2 months to 10 years). We contacted authors of these studies to inquire whether they conducted a sub-group analysis for participants aged six years and above. However, we were not able to get this information from the contacted authors. We have edited figure 1 to capture this information.

Results:

3\) Line 120: 94,978 this number includes control group as well?

� The 94,978 were survivors of neonatal insults. The control group is not included in the numbers, as indicated below.

Overall, 94,978 survivors of NNI were included in the studies in this review (page 7, line 122).

4\) Line 123-124: please mention the % of survivors in bracket, example NNJ (83.5%)

� We have amended this part as follows: The most examined or studied NNI were HIE (15.4%), NNJ (15.4%), and preterm birth (42.3%) (page 8, line 126).

5\) Did you consider any NNJ or HIE as a neonatal insult? If yes, your sample size is diluted. It would help if you include high risk insults such as NNJ requiring intensive phototherapy or exchange transfusion and moderate to severe HIEs.

� The systematic review and meta-analysis aimed to examine the long-term impact of NNI globally. We considered all articles that provided a clear diagnosis of NNJ or HIE, and we did not limit the inclusion of these studies based on the severity of NNJ or HIE as we intended to determine if any of the children irrespective of the severity of their condition develop neurocognitive or mental health sequelae. Additionally, given the limited long-term outcome studies in these conditions, we included all the studies with a clear diagnosis of NNJ or HIE despite the severity of the condition. However, we have noted this as a limitation of our study as indicated below.

Second, the inclusion of all children with a diagnosis of NNJ or HIE in the study without considering the severity levels might have diluted our sample (page 15, line 243-245).

6\) Similarly, a subgroup analysis of preterm birth by weight (ELBW, VLBW) will help.

� We have revised this part as follows: We conducted a sub group analysis of 15 preterm birth studies with extremely low birth weight participants, and similar results were obtained (page 8, line 138-139).

Discussion

7\) Overall discussion is well written, however following points may need attention.

Publication bias needs to be discussed.

� We have discussed the publication bias as follows:

Lastly, the results of this study should be cautiously interpreted as we found publication bias indicated by the asymmetry forest plot, which may imply that studies with significant results were more likely to be published than those with non-significant results. The publication bias could also reflect the high heterogeneity in the studies included in this systematic review and meta-analysis (page 15, line 251-255).

8\) High heterogeneity is important. Random effect model may be useful, however a subgroup analysis of studies with lower heterogeneity is important (example I2 \<60%)

� We thank the reviewer for this suggestion and acknowledge his recommendation for the subgroup analysis. However, the studies included in the meta-analysis in each condition are few and not optimal to conduct a subgroup analysis. We appreciate the reviewer's recognition of the robustness of the random effect model in dealing with heterogeneity in studies.

9\) No mention of any missing data and approach to address this important issue.

� In this systematic review and meta-analysis, we did not work with any primary data. We extracted secondary data from all the included studies, and we did not experience any missing data. Moreover, for the articles that we could not retrieve, their eligibility to be included in this study is doubtful since we are not sure whether they met the inclusion criteria for this systematic review and meta-analysis. We have corrected figure 1 to clarify that the 35 studies had a wide age range and not missing data as had previously been stated.
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